跳至主要内容
临床试验/jRCT2071210134
jRCT2071210134已完成不适用

A Clinical trial for Resminostat in Healthy Volunteers to Investigate the Effect of Food

Yakult Honsha Co., Ltd.0 个研究点目标入组 12 人开始时间: 2022年4月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized Controlled Trial
干预模型
Crossover Assignment
主要目的
Other
盲法
Open(masking Not Used)

入排标准

年龄范围
20age old over 至 45age old under(—)
性别
Male

入选标准

  • •Caucasian males aged between 20 (inclusive) and 45 years of age (inclusive) at the time informed consent is obtained.
  • •Body Mass Index between 18.5 kg/m2 (inclusive) and 30.0 kg/m2 (inclusive) at the time informed consent is obtained.
  • •Written informed consent obtained from the subject.

排除标准

  • •Clinical significant medical history or concomitant disease of any metabolic, allergic, dermatological, hepatic, renal, hematological, pulmonary, cardiovascular, gastrointestinal, neurological, respiratory, endocrine, or psychiatric disorder.
  • •History of surgery, such as gastrectomy, gastrointenstinal suture, or intenstinal resection that would potentially alter absorption of drugs. However, the history of appendicectomy is acceptable.
  • •History of clinically significant hypersensitivity or allergy to any drugs or foods.

结局指标

主要结局

-

PK: Pharmacokinetic parameters

次要结局

未报告次要终点

研究者

相似试验

A Clinical trial for Resminostat to Investigate the... | 临床试验